Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BG Medicine, Inc. | 140,000 | reported | 10 Dec 2012 | tx 1+140,000 |
| Molecular Insight Pharmaceuticals, Inc. | 50,000 | reported | 17 Nov 2009 | tx 2+225,000 |
| Coley Pharmaceutical Group, Inc. | 0 | reported | 04 Jan 2008 | tx 6+85,000−159,191 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Dec 2012 | GRANT_AWARD | BG Medicine, Inc. | 140,000 | 0.00 USD | deriv |
| 17 Nov 2009 | GRANT_AWARD | Molecular Insight Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 11 Aug 2009 | GRANT_AWARD | Molecular Insight Pharmaceuticals, Inc. | 175,000 | 0.00 USD | deriv |
| 04 Jan 2008 | TENDER | Coley Pharmaceutical Group, Inc. | 52,402 | — | deriv |
| 04 Jan 2008 | TENDER | Coley Pharmaceutical Group, Inc. | 58,123 | — | deriv |
| 04 Jan 2008 | TENDER | Coley Pharmaceutical Group, Inc. | 40,000 | — | deriv |
| 04 Jan 2008 | TENDER | Coley Pharmaceutical Group, Inc. | 8,666 | — | deriv |
| 18 Sept 2007 | GRANT_AWARD | Coley Pharmaceutical Group, Inc. | 40,000 | 0.00 USD | deriv |
| 16 Feb 2007 | GRANT_AWARD | Coley Pharmaceutical Group, Inc. | 45,000 | 0.00 USD | deriv |